STOCK TITAN
  1. Home
  2. Sec-filings
  3. COSM
  4. [8-K] Cosmos Health Inc. Reports Material Event

COSM back in compliance with Nasdaq Listing Rule 5550(a)(2)

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Cosmos Health Inc. (COSM) reported that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement. Nasdaq notified the company that the closing bid price of its common stock was at least $1.00 per share for 18 consecutive business days, from September 22, 2025 to October 15, 2025, and the matter is now closed.

The update follows a prior notice on November 6, 2024 that COSM was below the $1.00 threshold for 30 consecutive business days. The company furnished a press release about the compliance status under Regulation FD.

Positive

  • None.

Negative

  • None.

Insights

Nasdaq compliance restored after 18 trading days at or above $1.00.

Cosmos Health disclosed Nasdaq confirmed compliance with the minimum bid price rule after its stock closed at or above $1.00 for 18 consecutive business days spanning September 22, 2025 to October 15, 2025. This closes a deficiency first noted on November 6, 2024.

The practical effect is continued eligibility for the Nasdaq Capital Market, reducing delisting risk tied to this criterion. No financing, dilution, or operational changes are described in the excerpt.

Future listing status will depend on maintaining bid-price thresholds over time; subsequent filings or market data will reflect any changes.

Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

What did Cosmos Health (COSM) announce in its 8-K?
The company reported it regained compliance with Nasdaq Listing Rule 5550(a)(2) for the minimum bid price.

When did Nasdaq confirm COSM’s compliance with the $1.00 bid rule?
Nasdaq notified the company on October 15, 2025 after 18 consecutive business days at or above $1.00.

What was the qualifying bid price period for COSM?
From September 22, 2025 to October 15, 2025, the closing bid was at least $1.00 per share for 18 consecutive business days.

Why was COSM previously non-compliant?
On November 6, 2024, Nasdaq notified the company that its minimum bid price was below $1.00 for 30 consecutive business days.

What exhibits accompanied the 8-K for COSM?
Exhibit 99.1 is a press release dated October 16, 2025; 104 is the cover page Inline XBRL data file.

Does this 8-K describe any financing or dilutive actions?
No. It addresses Nasdaq bid price compliance and includes a related press release under Regulation FD.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

   

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) October 15, 2025

 

Cosmos Health Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

000-54436

 

27-0611758

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

5 AGIOU GEORGIOU, Pilea, Thessaloniki, Greece

 

55438

(Address of principal executive offices) 

 

(Zip Code)

 

Registrant’s telephone number, including area code (312) 865-0026

 

(Former name or former address, if changed since last report.)

 

Title of Each Class

 

Trading

Symbol

 

Name of Each Exchange

On Which Registered

Common Stock, $.001 par value

 

COSM

 

Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

ITEM 7.01 REGULATION FD DISCLOSURE.

 

On October 16, 2025, Cosmos Health Inc., a Nevada corporation (the “Company”), issued a press release announcing that it had regained compliance with Nasdaq Listing Rule 5550(a)(2). A copy of the press release is attached as Exhibit 99.1 to this Form 8-K.

 

In accordance with General Instruction B.2 to Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in that filing.

 

ITEM 8.01 OTHER EVENTS.

 

As previously disclosed, on November 6, 2024, the Company received a letter from the Listing Qualifications Department (the “Staff”) of The NASDAQ Stock Market, LLC (“Nasdaq”) notifying the Company that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the minimum bid price for the Company’s listed securities was less than $1 for the previous 30 consecutive business days.

 

On October 15, 2025, the Company received a letter from Nasdaq notifying the Company that the Staff had determined that the closing bid price of the Company’s common stock had been at $1.00 per share or greater for at least 18 consecutive business days, from September 22, 2025 to October 15, 2025, and, accordingly, that the Company had regained compliance with the Minimum Bid Price Requirement and the matter was now closed.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

 

(d) Exhibits

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press Release issued by Cosmos Health Inc., dated October 16, 2025

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
2

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

COSMOS HEALTH INC.

 

 

 

 

Date: October 17, 2025

By:

/s/ Georgios Terzis

Georgios Terzis

 

Chief Financial Officer

 

 

 
3

 

Source: View Original Filing on SEC EDGAR